Avalon Globocare sets 2026 virtual annual meeting

Avalon Globocare Corp. set its 2026 Annual Meeting of Stockholders for June 9, 2026, to be held virtually.

(Moderate)

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Avalon Globocare Corp. set its 2026 Annual Meeting of Stockholders for June 9, 2026, to be held virtually. Stockholders of record as of May 15, 2026 may vote at the meeting. The company also established April 12, 2026 as the deadline for shareholder proposals and director nominations.

Proposals for inclusion in the company’s proxy materials must meet the requirements of Rule 14a-8 and be received by the Corporate Secretary by April 12, 2026. Other proposals or director nominations must also comply with SEC rules, Delaware law and the company’s Amended and Restated Bylaws, or they will not be considered.

8-K Event Classification

Item 5.08 — Shareholder Director Nominations

1 item

Item 5.08 Shareholder Director Nominations Governance

Shareholder nominations for board of directors under proxy access rules. Rarely used -- the underlying SEC rule was vacated.

Key Figures

Annual meeting date: June 9, 2026 Record date: May 15, 2026 Proposal deadline: April 12, 2026 +1 more

4 metrics

Annual meeting date June 9, 2026 2026 Annual Meeting of Stockholders held virtually

Record date May 15, 2026 Stockholders of record entitled to vote at 2026 meeting

Proposal deadline April 12, 2026 Cutoff for Rule 14a-8 proposals and other nominations

Principal office address ZIP 07728 Freehold, NJ principal executive offices

Key Terms

Rule 14a-8, record date, proxy materials, Amended and Restated Bylaws, +1 more

5 terms

Rule 14a-8 regulatory

"pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended"

Rule 14a-8 is a U.S. Securities and Exchange Commission regulation that lets eligible shareholders put proposals on a public company’s proxy ballot for an annual meeting, provided they meet basic ownership and filing requirements. It matters to investors because it creates a formal way to raise governance or strategic issues and force a company-wide vote—like getting an item onto the agenda of a neighborhood association meeting once you’ve lived there long enough—so shareholders can push for change or influence management decisions.

record date financial

"The record date for the 2026 Annual Meeting is May 15, 2026."

The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.

proxy materials financial

"considered for inclusion in the Company’s proxy materials for the 2026 Annual Meeting"

Proxy materials are the packet of documents sent to shareholders that explain items to be voted on at a company meeting and include the actual ballot or instructions for casting a vote. Think of them as a voting packet that lays out who’s running the company, major proposals (like pay, mergers, or board changes), and arguments for and against each item. Investors care because those votes shape corporate direction, affect risk and future profits, and can influence share value.

Amended and Restated Bylaws regulatory

"must similarly make sure that such nomination or proposal and related notice comply with ... the Company’s Amended and Restated Bylaws"

A company’s amended and restated bylaws are its internal rulebook rewritten to include all changes in one updated document, replacing the old bylaws. For investors, this matters because the bylaws set how the board, shareholders and officers make decisions, hold votes and handle disputes; a new consolidated version can change voting rights, control mechanisms or procedures that affect corporate governance and the value or risk of an investment.

Annual Meeting of Stockholders financial

"resolved to hold its 2026 Annual Meeting of Stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Avalon Globocare (ALBT) holding its 2026 Annual Meeting?

Avalon Globocare will hold its 2026 Annual Meeting of Stockholders on June 9, 2026, as a virtual online meeting. Stockholders can participate and vote remotely, provided they are stockholders of record as of May 15, 2026, or are valid legal proxy holders.

What is the record date for Avalon Globocare (ALBT) 2026 Annual Meeting?

The record date for Avalon Globocare’s 2026 Annual Meeting is May 15, 2026. Only holders of common stock at the close of business on that date, or their legal proxy holders, are entitled to receive notice of and vote at the virtual annual meeting.

What is the deadline to submit shareholder proposals for Avalon Globocare (ALBT) 2026 meeting?

Shareholders must ensure proposals for inclusion in Avalon Globocare’s 2026 proxy materials under Rule 14a-8 are received by the Corporate Secretary by April 12, 2026. The company determined this date as a reasonable cut-off before printing and distributing its proxy materials.

How can shareholders nominate directors for Avalon Globocare (ALBT) 2026 Annual Meeting?

Shareholders may submit director nominations by delivering written notices to Avalon Globocare’s principal executive offices by April 12, 2026. Nominations must comply with SEC rules, Delaware law and the company’s Amended and Restated Bylaws, or they will be considered untimely and not brought before the meeting.

Where must Avalon Globocare (ALBT) shareholder proposals and nominations be sent?

Proposals and director nominations must be delivered or mailed to Avalon Globocare’s Corporate Secretary at 4400 Route 9 South, Suite 3100, Freehold, NJ 07728. They must arrive by April 12, 2026 and satisfy all applicable procedural and substantive requirements to be valid.

What happens if Avalon Globocare (ALBT) receives proposals after April 12, 2026?

Any director nominations or shareholder proposals received after April 12, 2026 will be treated as untimely. They will not be included in Avalon Globocare’s proxy materials for the 2026 Annual Meeting and will not be considered at the meeting itself under the disclosed procedures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/02/2026 - 04:10 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): April 2, 2026

AVALON GLOBOCARE CORP.

(Exact name of registrant as specified in its charter)

Delaware	001-38728	47-1685128
(State or other jurisdiction	(Commission File Number)	(IRS Employer
of incorporation)		Identification Number)

4400 Route 9 South, Suite 3100, Freehold, NJ 07728

(Address of principal executive offices, including zip code)

(732) 780-4400

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		ALBT		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.08. Shareholder Director Nominations.

On April 2, 2026, the Board of Directors of Avalon Globocare Corp. (the “Company”) resolved to hold its 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) on June 9, 2026. The 2026 Annual Meeting will be held virtually online by means of remote communication.

The record date for the 2026 Annual Meeting is May 15, 2026. Stockholders owning the Company’s common stock at the close of business on the record date, or their legal proxy holders, are entitled to vote at the 2026 Annual Meeting. The Company, however, reserves the right to change the record date or the meeting date.

Because the date of the 2026 Annual Meeting has been changed by more than 30 days from the one-year anniversary of the date of the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”), the deadline for stockholders’ nominations or proposals for consideration at the 2026 Annual Meeting set forth in the Company’s proxy statement for the 2025 Annual Meeting no longer applies. As such, the Company is filing this Current Report on Form 8-K to inform stockholders of this change and to provide the due date for the submission of any qualified stockholder proposals or qualified stockholder director nominations.

Stockholders of the Company who wish to have a proposal considered for inclusion in the Company’s proxy materials for the 2026 Annual Meeting pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (“Rule 14a-8”) must ensure that such proposal is delivered or mailed to and received by the Company’s Corporate Secretary at Company’s principal executive office located at 4400 Route 9 South, Suite 3100, Freehold, NJ 07728, no later than April 12, 2026, which the Company has determined to be a reasonable time before it expects to begin to print and distribute its proxy materials. Such proposals must comply with all applicable procedures and requirements of Rule 14a-8.

Any stockholder who intends to submit a director nomination or who intends to submit a proposal regarding any other matter of business at the 2026 Annual Meeting other than in accordance with Rule 14a-8 or otherwise must similarly make sure that such nomination or proposal and related notice comply with all applicable rules of the Securities and Exchange Commission, Delaware law and the Company’s Amended and Restated Bylaws, and are delivered to, or mailed to and received at, the Company’s principal executive offices set forth in the paragraph above on or before the close of business on April 12, 2026, which is the 10th day following the day on which the Company made a public announcement of the date of the 2026 Annual Meeting. Any director nominations and stockholder proposals received after this deadline will be considered untimely and will not be considered for inclusion in the proxy materials for the 2026 Annual Meeting nor will it be considered at the 2026 Annual Meeting.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AVALON GLOBOCARE CORP.

Dated: April 2, 2026	By:	/s/ Luisa Ingargiola
	Name:	Luisa Ingargiola
	Title:	Chief Financial Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents